ArticleJournal of proteome research2025
Dynamic Changes in Lymphocyte Subsets and Inflammation-Immune-Related Proteins in Patients with Thyroid Papillary Carcinoma before and after Radioactive Iodine Therapy.
Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multiplex Immune Profiling Reveals the Role of Serum Immune Proteomics in Predicting Response to Radioiodine after Total Resection of Papillary Thyroid Carcinoma.Journal of proteome research · 2026Article
- The predictive value of platelet parameters for the response to initialFrontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radioactive iodine therapy (RAIT) is one of the main treatment methods for patients with papillary thyroid carcinoma (PTC). Peripheral blood samples were collected from 29 PTC patients who underwent total thyroidectomy 1-2 days before RAIT (RAIT-0), 30 days after (RAIT-30), and 90 days after (RAIT-90). Flow cytometry was used to detect the absolute counts of peripheral blood lymphocyte subpopulations, and the Proximity Extension Assay (PEA) was used for targeted proteome quantification. We found that after RAIT, peripheral blood lymphocyte subpopulations and the abundance of inflammation-related proteins in PTC patients changed and did not return to pretreatment levels for a long time. The immune pathway "Cytokine-cytokine receptor interaction" related to cytokine signaling may be activated. In addition, there were two types of protein trends that were similar to the lymphocyte count trends. The five proteins with the greatest degree of trend change were MCP-1, TRAIL, TGF-alpha, Flt3L, and IL15. In RAIT-30 vs RAIT-0, B cells were significantly negatively correlated with protein Flt3L, and Th17 cells were significantly positively correlated with protein CRTAM. MCP-1, TRAIL, IL15, Flt3L, TGF-alpha, and CRTAM may be potential marker proteins for immune recovery in PTC patients after RAIT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.